Prof. Sufang Qiu 邱素芳
Chief Physician, Professor
Department of Radiation Oncology, Fujian Cancer Hospital, Fuzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiotherapy and comprehensive treatment for head and neck malignancies, including nasopharyngeal, tongue, oropharyngeal, hypopharyngeal, laryngeal, and paranasal sinus cancers. Techniques include brachytherapy, 3D conformal intensity-modulated radiotherapy, and TOMO.
Dr. Qiu is a Professor, Doctoral Supervisor, and Chief Physician at Fujian Cancer Hospital. Holding a doctorate in oncology, Dr. Qiu serves as Administrative Director of Head and Neck Tumor Radiotherapy and Executive Director of the Nasopharyngeal Cancer Diagnosis and Treatment Center at Fudan University Shanghai Cancer Center Fujian Hospital.
Professional roles
- Vice Chair, Youth Committee of the Radiation Oncology Branch, Chinese Medical Association (8th Term)
- Vice Chair, Nasopharyngeal Cancer Biomarker Expert Committee, Tumor Marker Professional Committee, China Anti-Cancer Association
- Standing Committee Member, Radiation Medicine Professional Committee, China Anti-Cancer Association
- Member, Head and Neck Tumor Professional Committee, Chinese Society of Clinical Oncology (CSCO)
Name order: in Chinese the family name comes first (Qiu Sufang). Papers usually list the name as Sufang Qiu or Qiu S.
Selected publications
98 papers on PubMed matched by name and affiliation; 55 as first or senior author since 2016. Most recent first- or senior-author papers:
- Head Neck, 2026 (senior author): Local Consolidative Radiotherapy Combined With Immunochemotherapy for De Novo Metastatic Nasopharyngeal Carcinoma: A Meta-Analysis. PubMed 42366617
- Clin Immunol, 2026 (senior author): LGALS9 interacts with CD44 on CD8(+) T cells to impair activation and mediate immune evasion in nasopharyngeal carcinoma. PubMed 43020208
- J Magn Reson Imaging, 2026 (senior author): MRI-Derived Lymph Node Characteristics for Risk Stratification of Distant Metastasis in Locoregionally Advanced Nasopharyngeal Carcinoma. PubMed 42969888
- Ther Adv Med Oncol, 2026 (senior author): Risk stratification and boost dose optimization for locoregionally advanced nasopharyngeal carcinoma with residual lesions based on clinical stage and post-radiotherapy EBV DNA. PubMed 42643794
- Anal Methods, 2026 (senior author): Label-free cervical cancer detection in tissue samples using Raman spectroscopy combined with machine learning technology. PubMed 42396761
- Front Oncol, 2026 (senior author): Glandular tissue-based versus anatomical landmark-based CTV delineation in postoperative breast cancer radiotherapy: a dosimetric comparison. PubMed 42294326
- Radiat Oncol, 2026 (senior author): A time-adapted risk stratification framework guided by longitudinal post-radiotherapy EBV DNA clearance for high-risk nasopharyngeal carcinoma patients. PubMed 41888863
- Ther Adv Med Oncol, 2026 (senior author): Dynamic disease progression in non-metastatic nasopharyngeal carcinoma post-radical radiotherapy: a Markov model-based analysis in a Chinese cohort. PubMed 41883863
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion